Soleno Therapeutics (SLNO) Revenue (QoQ) (2015 - 2026)

Soleno Therapeutics (SLNO) Revenue (QoQ) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Soleno Therapeutics 874.25 Mn 618.67 Mn 93.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.13%
Dec 31, 2025 38.95%
Sep 30, 2025 102.16%
Jun 30, 2017 -99.62%
Mar 31, 2017 -81.73%
Dec 31, 2016 340.97%
Sep 30, 2016 16,350.00%
Jun 30, 2016 -99.55%
Mar 31, 2016 15.36%
Dec 31, 2015 56.87%
Sep 30, 2015 154.64%
Jun 30, 2015 340.91%